Beckman Coulter

CD314 (NKG2D)

#A08934 · western blot

3
Citing papers
29
Combined citations
Supplier page Find this product

Research areas

CAR-T cell therapy research3Immune Cell Function and Interaction2Cancer Immunotherapy and Biomarkers1Protein Degradation and Inhibitors1Renal cell carcinoma treatment1T-cell and B-cell Immunology1

Papers citing this product

1
Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinoma
International Journal of Oncology·2020·13 cit.·DOI
2
Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing Genes
Journal of Immunology Research·2024·8 cit.·DOI
3
Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer
Oncology Letters·2023·8 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
CD314 (NKG2D) Monoclonal Antibody (CX5), APC, eBioscienceRatThermo Fisher Scientific———
PE anti-human CD314 (NKG2D)MouseBioLegend———
CD314 (NKG2D) Antibody, anti-human, BiotinMouseMiltenyi Biotec———
CD314 (NKG2D)-PEMouseMiltenyi Biotec———
CD314 (NKG2D) Antibody, anti-human, pureMouseMiltenyi Biotec———

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.